Your session is about to expire
← Back to Search
"PICU Up!" Early Mobility Intervention for Critically Ill Children (PICU Up! Trial)
N/A
Recruiting
Led By Sapna Kudchadkar, MD, PhD
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Invasive mechanical ventilation via oral or nasal endotracheal tube ≥ 48 hours at 7 a.m. on PICU Day 3
Be younger than 65 years old
Must not have
Open chest or open abdomen
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through day 21
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new interprofessional intervention (PICU Up!) to help decrease the duration of mechanical ventilation for critically ill children, with the goal of improving physical and psychological outcomes.
Who is the study for?
This trial is for children in the PICU who have been on a breathing machine through their mouth or nose for at least 48 hours by the morning of their third day in care. It's not for kids if life support might be stopped soon, they have an open chest or abdomen, or are using ECMO (a heart-lung bypass machine).
What is being tested?
The 'PICU Up!' intervention is being tested to see if it can reduce how long critically ill children need mechanical ventilation. It combines managing sedation, preventing delirium, promoting sleep, and involving families to help these kids start moving sooner and more safely.
What are the potential side effects?
Since 'PICU Up!' focuses on early mobility and involves non-drug interventions like physical activity and family involvement, there aren't typical medication side effects. However, there may be risks associated with moving critically ill patients too early or quickly.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have been on a breathing machine for more than 48 hours.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have had an open chest or abdomen surgery.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ through day 21
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through day 21
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Duration of Mechanical Ventilation
Secondary study objectives
Change in Functional Status as assessed by the Pediatric Cerebral Performance Category (PCPC) scale
Change in Functional Status as assessed by the Pediatric Overall Performance Category (POPC) scale
Proportion of Days with Delirium
Other study objectives
Mean daily Benzodiazepine exposure
Mean daily Opioid exposure
Number of patients discharged to home
+8 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Active Control
Group I: Baseline/Pre-implementationActive Control1 Intervention
Usual PICU care
Group II: Intervention/Post-implementationActive Control1 Intervention
PICU Up! is a multifaceted, inter-professional pathway that is integrated into routine PICU practice to safely optimize early and progressive patient mobility.
Find a Location
Who is running the clinical trial?
Johns Hopkins UniversityLead Sponsor
2,323 Previous Clinical Trials
14,872,867 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,051 Previous Clinical Trials
2,730,104 Total Patients Enrolled
Sapna Kudchadkar, MD, PhDPrincipal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been on a breathing machine for more than 48 hours.You are currently on life support or expected to be taken off life support within 48 hours.You are currently using Extracorporeal Membrane Oxygenation (ECMO).I have had an open chest or abdomen surgery.
Research Study Groups:
This trial has the following groups:- Group 1: Baseline/Pre-implementation
- Group 2: Intervention/Post-implementation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger